Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Rothstein

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Scientific Reports|July 5, 2019
FGF family members differentially regulate maturation and proliferation of stem cell-derived astrocytesEkaterina Savchenko, Gabriel N Teku, Antonio Boza-Serrano, et al.
The Journal of Experimental Medicine|February 20, 2008
Glutamate mediates platelet activation through the AMPA receptorCraig N Morrell, Henry Sun, Masahiro Ikeda, et al.
Muscle & Nerve|June 6, 2025
Efficacy and Safety of Once Daily Dosing vs. Approved On/Off Dosing of Edaravone Oral Suspension Up to 48 Weeks in Patients With Amyotrophic Lateral Sclerosis (Study MT-1186-A02)Jeffrey Rothstein, Angela Genge, Shari De Silva, et al.
Muscle & Nerve|December 23, 2025
Phase 3b Extension Study MT-1186-A04 to Evaluate the Continued Efficacy and Safety of Edaravone Oral Suspension for Up to an Additional 48 Weeks in Patients With Amyotrophic Lateral SclerosisAngela Genge, Jeffrey Rothstein, Shari De Silva, et al.
Science Translational Medicine|October 2, 2015
Human endogenous retrovirus-K contributes to motor neuron diseaseWenxue Li, Myoung-Hwa Lee, Lisa Henderson, et al.
Cell Reports|May 31, 2016
Concordant but Varied Phenotypes among Duchenne Muscular Dystrophy Patient-Specific Myoblasts Derived using a Human iPSC-Based ModelIn Young Choi, HoTae Lim, Kenneth Estrellas, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 18, 2013
Deciphering amyotrophic lateral sclerosis: what phenotype, neuropathology and genetics are telling us about pathogenesisJohn Ravits, Stanley Appel, Robert H Baloh, et al.
Scientific Data|January 11, 2023
NeuroLINCS Proteomics: Defining human-derived iPSC proteomes and protein signatures of pluripotencyAndrea D Matlock, Vineet Vaibhav, Ronald Holewinski, et al.
The Lancet. Neurology|March 17, 2007
Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of dataJennifer C Schymick, Sonja W Scholz, Hon-Chung Fung, et al.
The Lancet. Neurology|April 2, 2013
An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man studyTimothy M Miller, Alan Pestronk, William David, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Scientific Reports|July 5, 2019
FGF family members differentially regulate maturation and proliferation of stem cell-derived astrocytesEkaterina Savchenko, Gabriel N Teku, Antonio Boza-Serrano, et al.
The Journal of Experimental Medicine|February 20, 2008
Glutamate mediates platelet activation through the AMPA receptorCraig N Morrell, Henry Sun, Masahiro Ikeda, et al.
Muscle & Nerve|June 6, 2025
Efficacy and Safety of Once Daily Dosing vs. Approved On/Off Dosing of Edaravone Oral Suspension Up to 48 Weeks in Patients With Amyotrophic Lateral Sclerosis (Study MT-1186-A02)Jeffrey Rothstein, Angela Genge, Shari De Silva, et al.
Muscle & Nerve|December 23, 2025
Phase 3b Extension Study MT-1186-A04 to Evaluate the Continued Efficacy and Safety of Edaravone Oral Suspension for Up to an Additional 48 Weeks in Patients With Amyotrophic Lateral SclerosisAngela Genge, Jeffrey Rothstein, Shari De Silva, et al.
Science Translational Medicine|October 2, 2015
Human endogenous retrovirus-K contributes to motor neuron diseaseWenxue Li, Myoung-Hwa Lee, Lisa Henderson, et al.
Cell Reports|May 31, 2016
Concordant but Varied Phenotypes among Duchenne Muscular Dystrophy Patient-Specific Myoblasts Derived using a Human iPSC-Based ModelIn Young Choi, HoTae Lim, Kenneth Estrellas, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|May 18, 2013
Deciphering amyotrophic lateral sclerosis: what phenotype, neuropathology and genetics are telling us about pathogenesisJohn Ravits, Stanley Appel, Robert H Baloh, et al.
Scientific Data|January 11, 2023
NeuroLINCS Proteomics: Defining human-derived iPSC proteomes and protein signatures of pluripotencyAndrea D Matlock, Vineet Vaibhav, Ronald Holewinski, et al.
The Lancet. Neurology|March 17, 2007
Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of dataJennifer C Schymick, Sonja W Scholz, Hon-Chung Fung, et al.
The Lancet. Neurology|April 2, 2013
An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man studyTimothy M Miller, Alan Pestronk, William David, et al.
Pageof 3